3226 - 3250 of 6568 Results
Title
Year
-
OPENTitle: Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriersJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page: 248End Page: 248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00248Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2014.00248/pdfCitation Count: 77
-
OPENTitle: Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)Journal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: 553635End Page: 553635Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.553635Best OA location URL: https://escholarship.org/uc/item/46x4b7c2Citation Count: 36
-
OPENTitle: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's ResearchJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol:Issue #:Start Page: 1316End Page: 24Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.011940Best OA location URL: https://doi.org/10.1242/dmm.011940Citation Count: 40
-
OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/137434Citation Count: 24
-
OPENTitle: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change MeasuresJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 9Issue #: 4Start Page: 665End Page: 679Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181518Best OA location URL: https://escholarship.org/uc/item/2w68g45qCitation Count: 25
-
OPENTitle: Beyond Alzheimer’s disease—translating biomarker insights across CNS diseasesJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 17Issue #: 823Start Page: eadr2511End Page: eadr2511Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adr2511Best OA location URL: https://pubmed.ncbi.nlm.nih.gov/41191776/Citation Count: 2
-
OPENTitle: Remote Digital Monitoring for Medical Product DevelopmentJournal Name: Clinical and Translational SciencePublisher: WileyVol: 14Issue #: 1Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cts.12851Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12851Citation Count: 22
-
OPENTitle: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 3Start Page: 284End Page: 292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.12915Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12915Citation Count: 20
-
OPENTitle: Use of an Online Portal to Facilitate Clinical Trial Recruitment: A Preliminary Analysis of Fox Trial FinderJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 5Issue #: 1Start Page: 55End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-140522Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd140522?id=journal-of-parkinsons-disease%2Fjpd140522Citation Count: 14
-
OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://doi.org/10.1002/alz.12732Citation Count: 12
-
OPENTitle: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s DiseaseJournal Name: MDM Policy & PracticePublisher: SAGE PublicationsVol: 6Issue #: 1Start Page: 23814683211021380End Page: 23814683211021380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/23814683211021380Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380Citation Count: 14
- Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to Action2022OPENTitle: Including People with Parkinson’s Disease in Clinical Study Design and Execution: A Call to ActionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 4Start Page: 1359End Page: 1363Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223190Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223190?id=journal-of-parkinsons-disease%2Fjpd223190Citation Count: 15
-
OPENTitle: Use of Bayesian decision analysis to maximize value in patient-centered randomized clinical trials in Parkinson’s diseaseJournal Name: Journal of Biopharmaceutical StatisticsPublisher: Informa UK LimitedVol: 35Issue #: 5Start Page: 981End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/10543406.2023.2170400Best OA location URL: https://doi.org/10.1080/10543406.2023.2170400Citation Count: 8
-
OPENTitle: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 348End Page: 348Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01180-zBest OA location URL: https://www.nature.com/articles/s41531-025-01180-z_reference.pdfCitation Count: 4
-
OPENTitle: A Coalition to Advance Treatments for Parkinson’s Disease, Dementia with Lewy Bodies, and Related DisordersJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1105End Page: 1114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230257Best OA location URL: https://doi.org/10.3233/jpd-230257Citation Count: 5
-
OPENTitle: The patient-specific mouse model with Foxg1 frameshift mutation provides insights into the pathophysiology of FOXG1 syndromeJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 4760End Page: 4760Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41467-025-59838-4Best OA location URL: https://www.nature.com/articles/s41467-025-59838-4.pdfCitation Count: 4
-
OPENTitle: Longitudinal characterization of clinical, developmental, and behavioral phenotypes in 101 children and adults with FOXG1 syndromeJournal Name: Journal of Neurodevelopmental DisordersPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page: 64End Page: 64Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s11689-025-09653-1Best OA location URL: https://jneurodevdisorders.biomedcentral.com/counter/pdf/10.1186/s11689-025-09653-1Citation Count: 3
-
OPENTitle: Design considerations for C9orf72 disease prevention trialsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 11Start Page: 3844End Page: 3855Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf290Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf290/63960980/awaf290.pdfCitation Count: 2
-
OPENTitle: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 5Issue #: 11Start Page: 917End Page: 923Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8Best OA location URL: http://orbilu.uni.lu/handle/10993/17148Citation Count: 82
-
OPENTitle: Increasing Efficiency of Recruitment in Early Parkinson’s Disease Trials: A Case Study Examination of the STEADY-PD III TrialJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 4Start Page: 685End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-171199Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd171199?id=journal-of-parkinsons-disease%2Fjpd171199Citation Count: 20
-
OPENTitle: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevinJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 10Start Page: 695End Page: 699Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3bBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2889226Citation Count: 15
-
OPENTitle: Review of the Effects of Lifestyle Modification on Parkinson’s DiseaseJournal Name: American Journal of Lifestyle MedicinePublisher: SAGE PublicationsVol:Issue #:Start Page: 15598276251384591End Page: 15598276251384591Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15598276251384591Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15598276251384591?download=trueCitation Count: 2
- Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease2016OPENTitle: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 89End Page: 94Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-161031Citation Count: 15
-
OPENTitle: Initiation of antidepressant medication and risk of incident stroke: using the Adult Changes in Thought cohort to address time-varying confoundingJournal Name: Annals of EpidemiologyPublisher: Elsevier BVVol: 35Issue #:Start Page: 42End Page: 47.e1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.annepidem.2019.04.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8074509Citation Count: 13
- Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation2020OPENTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/58956Citation Count: 12